329. Aniridia Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 5 / Drugs : 6 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Ataluren
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States
Blood specimen
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
Conjunctival impression
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan
Peripheral venous blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Questionnaire
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
PTC Therapeutics
2018 Phase 2 NCT04117880 -
2016 Phase 2 NCT02647359 Canada;United States
Blood specimen
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
Conjunctival impression
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Mitomycin
Department of Ophthalmology, Keio University School of Medicine
2013 - JPRN-UMIN000002948 Japan
Peripheral venous blood sample
Fondation Ophtalmologique Adolphe de Rothschild
2023 - NCT05400590 France
Questionnaire
M.D. Anderson Cancer Center
1980 - NCT00503893 United States
